Error: Could not add to watchlist. X
+ Watchlist

Paladin Labs Inc

PLB:CN
Acquired
PLB:CN was acquired by ENDP:US
CAD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
2.45
Market Cap (CAD)
-
Shares Outstanding (m)
20.765
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Paladin Labs, Inc. develops, markets, and distributes pharmaceuticals. The Company offers a variety of products in urology, dermatology, rheumatology, and other specialty markets.
Address
6111 Royalmount Avenue
Suite 102
Montreal, QC H4P 2T4
Canada
Phone
1-514-340-1112
Show More